Financial PerformanceFinancial results show continued growth in an expanding market, meeting growth expectations both sequentially and in year-over-year comparisons.

Product InnovationZomedica has introduced several new assays for use with its TRUFORMA diagnostics platform, allowing veterinary practices to run tests without sending samples to an outside lab.

Sales GrowthThe TRUFORMA assays have been one of the sources of sales growth over the past year.

Bears Say

Price WeaknessAlthough Zomedica has made fundamental progress, the price weakness led to delisting and further price weakness.

Stock Price And DelistingThe closing price of Zomedica stock fell below $0.10 per share, forcing the delisting of ZOM shares.

Zomedica News

Zomedica Reports Record Revenue Growth in Q3 2025

Zomedica Pharma ( ($ZOMDF) ) has released its Q3 earnings. Here is a breakdown of the information Zomedica...

2M ago

ZOMDF

Zomedica Achieves Record Third Quarter Revenue Growth in 2025

Zomedica ( ($ZOMDF) ) has issued an announcement. Zomedica announced a 16% increase in revenue for the third...

2M ago

Zomedica Corp. Reports Q2 2025 Financial Results

Zomedica Pharma ( ($ZOMDF) ) has released its Q2 earnings. Here is a breakdown of the information Zomedica...

4M ago

ZOMDF

Zomedica Achieves Record Revenue Growth in Q2 2025

Zomedica ( ($ZOMDF) ) has provided an update. Zomedica reported a 14% increase in revenue for the second...

5M ago

Zomedica Shareholders Approve Directors, Reject Compensation

Zomedica ( ($ZOMDF) ) has provided an update. On June 10, 2025, Zomedica held its annual shareholder meeting...

7M ago

Zomedica Reports Q1 2025 Growth Amid Strategic Expansion

Zomedica Pharma ( ($ZOMDF) ) has released its Q1 earnings. Here is a breakdown of the information Zomedica...

8M ago

ZOMDF

Zomedica CFO Scott Jordan Resigns, Interim Replacement Named

The latest announcement is out from Zomedica ( ($ZOMDF) ). On April 25, 2025, Scott Jordan resigned as...

8M ago

Zscaler, Rocket Lab, American Tower, Intuit, and Zomedica: Insider Moves Unveiled!

Insiders have been trading these 5 stocks: (($ZS)), (($RKLB)), (($AMT)), (($INTU)) and (($ZOMDF)). Here is a breakdown of...

9M ago

AMT

Zomedica’s Earnings Call: Growth Amid Challenges

Zomedica Pharma (($ZOMDF)) has held its Q4 earnings call. Read on for the main highlights of the call....

10M ago

ZOMDF

Zomedica Achieves Record Revenue and Strategic Growth in 2024

Zomedica ( ($ZOMDF) ) has issued an announcement. Zomedica reported record revenue of $7.9 million for the fourth...

10M ago

ZOMDF FAQ

What was Zomedica’s price range in the past 12 months?

Zomedica lowest stock price was $0.01 and its highest was $0.16 in the past 12 months.

What is Zomedica’s market cap?

Zomedica’s market cap is $105.64M.

When is Zomedica’s upcoming earnings report date?

Zomedica’s upcoming earnings report date is Mar 04, 2026 which is in 64 days.

How were Zomedica’s earnings last quarter?

Zomedica released its earnings results on Nov 04, 2025. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.

Is Zomedica overvalued?

According to Wall Street analysts Zomedica’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Zomedica pay dividends?

Zomedica does not currently pay dividends.

What is Zomedica’s EPS estimate?

Zomedica’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Zomedica have?

Zomedica has 979,949,650 shares outstanding.

What happened to Zomedica’s price movement after its last earnings report?

Zomedica reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Zomedica?

Currently, no hedge funds are holding shares in ZOMDF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Zomedica Stock Smart Score

Neutral

Fundamentals

Return on Equity

-50.95%

Trailing 12-Months

Asset Growth

-37.93%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Zomedica

Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.

Zomedica (ZOMDF) Earnings & Revenues

Historic Earnings Reports

ZOMDF Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

Zomedica's earnings call highlighted strong revenue growth, especially in the diagnostics segment, and successful international expansion. However, these positives were countered by significant challenges, including the delisting from the NYSE and an increased net loss. The company's strong liquidity position and product innovation are promising, but these are tempered by market and operational challenges.View all ZOMDF earnings summaries